7 results match your criteria: "2 New York University Langone Medical Center[Affiliation]"
Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide.
Biol Blood Marrow Transplant
August 2020
Blood & Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio. Electronic address:
Post-transplant cyclophosphamide (PTCy) has significantly increased the successful use of haploidentical donors with a relatively low incidence of graft-versus-host disease (GVHD). Given its increasing use, we sought to determine risk factors for GVHD after haploidentical hematopoietic cell transplantation (haplo-HCT) using PTCy. Data from the Center for International Blood and Marrow Transplant Research on adult patients with acute myeloid leukemia, acute lymphoblastic leukemia, myelodysplastic syndrome, or chronic myeloid leukemia who underwent PTCy-based haplo-HCT (2013 to 2016) were analyzed and categorized into 4 groups based on myeloablative (MA) or reduced-intensity conditioning (RIC) and bone marrow (BM) or peripheral blood (PB) graft source.
View Article and Find Full Text PDFDasotraline in Children with Attention-Deficit/Hyperactivity Disorder: A Six-Week, Placebo-Controlled, Fixed-Dose Trial.
J Child Adolesc Psychopharmacol
March 2019
4 Sunovion Pharmaceuticals, Inc. , Marlborough, Massachusetts and Fort Lee, New Jersey.
Objective: Dasotraline is a potent inhibitor of presynaptic dopamine and norepinephrine reuptake with a pharmacokinetic profile characterized by slow absorption and a long elimination half-life. The aim of this study was to evaluate the efficacy and safety of dasotraline in children with attention-deficit/hyperactivity disorder (ADHD).
Methods: Children aged 6-12 years with a Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) diagnosis of ADHD were randomized to 6 weeks of double-blind once-daily treatment with dasotraline (2 or 4 mg) or placebo.
Comparing Dose-Length Product-Based and Monte Carlo Simulation Organ-Based Calculations of Effective Dose in 16- and 64-MDCT Examinations Using Automatic Tube Current Modulation.
AJR Am J Roentgenol
March 2018
1 George Washington University Hospital, 900 23rd St NW, Washington, DC 20037.
Objective: The purpose of this study is to compare dose-length product (DLP)-based calculation of effective dose (ED) with Monte Carlo simulation organ-based calculation of effective dose (ED) in 16- and 64-MDCT examinations, with the use of clinical examinations with automatic tube current modulation.
Materials And Methods: Dose data were obtained from 50 consecutive unenhanced head CT examinations, unenhanced chest CT examinations, and unenhanced and contrast-enhanced abdominopelvic CT examinations performed using 16- and 64-MDCT scanners, as well as from 50 pulmonary CT angiography (CTA) examinations performed using a 64-MDCT scanner and 31 pulmonary CTA examinations performed using a 16-MDCT scanner. The ED and the mean patient effective diameter were calculated using commercially available software.
A multicenter, randomized, placebo-controlled study to evaluate the efficacy and safety of Varithena® (polidocanol endovenous microfoam 1%) for symptomatic, visible varicose veins with saphenofemoral junction incompetence.
Phlebology
April 2017
2 New York University Langone Medical Center, New York, NY, USA.
Objectives A randomized, placebo-controlled, multicenter study was conducted to evaluate the safety and efficacy of polidocanol endovenous microfoam (1%, Varithena® [polidocanol injectable foam], BTG International Ltd.). Methods Patients (n = 77) with symptomatic, visible varicose veins were randomized to treatment with either Varithena 1% or placebo.
View Article and Find Full Text PDFA Systematic Review of Family Witnessed Resuscitation and Family Witnessed Invasive Procedures in Adults in Hospital Settings Internationally - Part II: Perspectives of Healthcare Providers.
JBI Libr Syst Rev
January 2012
1. University of Medicine and Dentistry of New Jersey, School of Nursing. The New Jersey Center for Evidence Based Practice: A Collaborating Center of the Joanna Briggs Institute, 65 Bergen Street, GA-214, Newark, NJ 07101 2. New York University Langone Medical Center, Health Sciences Libraries, 550 First Avenue, New York, NY 10016.
Background: Medicalization of care has removed family members from loved ones during critical events. Family Witnessed Resuscitation and Family Witnessed Invasive Procedures represent patient / family centered care options that can assist with having the family at the bedside during this perilous time.
Objectives: The objective was to examine the evidence on FWR and FWIP in adults from the perspective of healthcare providers.
A Systematic Review of Family Witnessed Resuscitation and Family Witnessed Invasive Procedures in Adults in Hospital Settings Internationally - Part I: Perspectives of Patients and Families.
JBI Libr Syst Rev
January 2012
1. University of Medicine and Dentistry of New Jersey, School of Nursing. The New Jersey Center for Evidence Based Practice: A Collaborating Center of the Joanna Briggs Institute, 65 Bergen Street, GA-214, Newark, NJ 07101 2. New York University Langone Medical Center, Health Sciences Libraries, 550 First Avenue, New York, NY 10016.
Background: Medicalization of care has removed family members from loved ones during critical events. Family Witnessed Resuscitation and Family Witnessed Invasive Procedures represent patient / family centered care options that can assist with having the family at the bedside during this perilous time.
Objectives: The objective was to examine the evidence on FWR and FWIP in adults from the perspective of patients and relatives.